Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
Titel:
Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
Auteur:
Beheshti, Mohsen Taimen, Pekka Kemppainen, Jukka Jambor, Ivan Müller, Andre Loidl, Wolfgang Kähkönen, Esa Käkelä, Meeri Berndt, Mathias Stephens, Andrew W. Minn, Heikki Langsteger, Werner